Jenscare Scientific Co., Ltd. (HKG:9877)
8.76
-0.24 (-2.67%)
Jan 21, 2026, 4:08 PM HKT
Jenscare Scientific Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -244.81 | -177.51 | -371.74 | -439.31 | -500.52 | -299.45 |
Depreciation & Amortization | 10.8 | 12.3 | 11.57 | 8.86 | 5.11 | 3.33 |
Other Amortization | 0.54 | 0.54 | 0.49 | 0.34 | 0.15 | 0.01 |
Loss (Gain) From Sale of Assets | 0.06 | 0.09 | 0.01 | 0.01 | 0.01 | 0.04 |
Asset Writedown & Restructuring Costs | 5.54 | 6.71 | - | - | - | - |
Loss (Gain) From Sale of Investments | -7.07 | -10.84 | 0.17 | -0.72 | -6.49 | -1.5 |
Loss (Gain) on Equity Investments | - | - | -18.95 | -16.17 | -1.34 | - |
Stock-Based Compensation | 63.18 | 5.7 | 205.39 | 317.88 | 366.51 | 252.15 |
Other Operating Activities | 7.56 | -1.21 | -9.85 | -36.01 | 6.74 | 0.32 |
Change in Inventory | -13.35 | -12.21 | -18.23 | -5.22 | -3.15 | -0.06 |
Change in Accounts Payable | 0.76 | -4.24 | 5.38 | 2.51 | 4.66 | 0.59 |
Change in Other Net Operating Assets | -33.56 | -36.88 | -26.68 | 9.36 | -13.58 | -2.29 |
Operating Cash Flow | -202.89 | -217.55 | -222.44 | -158.48 | -141.89 | -46.85 |
Capital Expenditures | -55.79 | -71.26 | -78.2 | -21.66 | -13.28 | -2.09 |
Sale of Property, Plant & Equipment | - | - | 0.02 | - | - | - |
Sale (Purchase) of Intangibles | -0.36 | -0.43 | -0.43 | -2.14 | -2.08 | -0.48 |
Sale (Purchase) of Real Estate | - | - | - | -25.75 | - | - |
Investment in Securities | 79.51 | 77.28 | 436.75 | -97.03 | -459.73 | 9.19 |
Other Investing Activities | 30.63 | - | - | - | 0.01 | - |
Investing Cash Flow | 53.99 | 5.59 | 358.13 | -146.58 | -475.07 | 6.62 |
Short-Term Debt Issued | - | 3.2 | - | - | - | 56.2 |
Long-Term Debt Issued | - | 16.24 | 40.75 | - | - | - |
Total Debt Issued | 4.77 | 19.44 | 40.75 | - | - | 56.2 |
Short-Term Debt Repaid | - | - | - | - | - | -58.7 |
Long-Term Debt Repaid | - | -2.89 | -3.02 | -1.92 | -2.36 | -0.72 |
Total Debt Repaid | -10.08 | -2.89 | -3.02 | -1.92 | -2.36 | -59.42 |
Net Debt Issued (Repaid) | -5.32 | 16.54 | 37.73 | -1.92 | -2.36 | -3.22 |
Issuance of Common Stock | - | - | 22.89 | 189.35 | 1,078 | 400 |
Repurchase of Common Stock | -65.24 | -127.25 | -5.04 | - | - | - |
Other Financing Activities | -0.01 | -0.03 | 0.86 | 1.5 | -0.37 | -13.27 |
Financing Cash Flow | -70.56 | -110.74 | 56.44 | 188.93 | 1,075 | 383.51 |
Foreign Exchange Rate Adjustments | 0.55 | 0.87 | 8.33 | 42.91 | -6.84 | - |
Net Cash Flow | -218.91 | -321.84 | 200.46 | -73.23 | 451.52 | 343.28 |
Free Cash Flow | -258.68 | -288.81 | -300.64 | -180.14 | -155.17 | -48.95 |
Free Cash Flow Per Share | -0.64 | -0.71 | -0.72 | -0.49 | -0.46 | -0.18 |
Cash Interest Paid | 0.14 | 0.16 | 0.14 | - | - | - |
Levered Free Cash Flow | -176.07 | -207.91 | -155.47 | -12.21 | 53.01 | - |
Unlevered Free Cash Flow | -175.89 | -207.73 | -155.38 | -12.14 | 53.09 | - |
Change in Working Capital | -38.67 | -53.32 | -39.53 | 6.65 | -12.07 | -1.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.